Loading company…
Dublin company developing Lenire, an at-home tinnitus treatment device using bimodal neuromodulation.
Founded in 2010 in Dublin, Ireland, by Ross O'Neill, Neuromod Devices Limited develops medical technology for treating tinnitus. Its prescription, at-home device Lenire combines auditory and electrical stimulation, and has CE marking in Europe and FDA De Novo approval in the United States. The company raised EUR 10.00 mn in Series B funding, co-led by Fountain Healthcare Partners and Panakes Partners, with its most recent round on March 11, 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in